Keeping Current
Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach
21:05
Intervening early can stop metabolic dysfunction-associated steatohepatitis (MASH) progressing to fibrosis. Which of your patients with type 2 diabetes (T2D) or obesity need treatment, and what therapies are available?
Credit available for this activity expires: 3/26/27 Earn Credit / Learning Objectives & Disclosures:…